Cardiovascular complications are one of the frequent ®ndings encountered in hyperthyroid states. By exerting direct anabolic effects on the heart, 1 elevated thyroid hormones caused increased left ventricular mass and contractibility. 2 Hence, being clinically euthyroid but biochemically thyrotoxic, patients with subclinical thyrotoxicosis have a higher risk of developing atrial ®brillation or cardiomyopathy. 3 Detection and proper management of this condition is therefore important.
We report a study carried out to evaluate whether, apart from the characteristic suppressed thyroid-stimulating hormone (TSH) but normalized free thyroxine (fT 4 ) and free triiodothyronine (fT 3 ) levels, other biochemical parameters could be used as indices of subclinical hyperthyroidism.
PATIENTS AND METHODS
Serum samples from 167 thyroid patients were analysedfor TSH, fT 4 , fT 3 , angiotensin-converting enzyme (ACE) activity, liver alkaline phosphatase (ALP), creatine kinase (CK) and creatine kinase M subunit (CK-MB) activity. Ultrasensitive TSH was measured by Abbott IMx, and fT 3 and fT 4 were measured using DPC (USA) Coat-A-Count radioimmunoassay kits. Reagents for CK and ALP were from Roche Products Ltd (UK), those for CK-MB were from Randox Laboratories Ltd (UK) and the ACE kit was from Buhlmann Laboratories AG.
Data were analysed by SAS statistical package, using the Wilcoxon rank sum test for differences between means and Spearman's correlation test for association between variables. Unless otherwise stated, all levels of hormones and enzymes are quoted as mean+ standard error of the mean (SEM). The level of signi®cance was set at P50´01.
RESULTS
Patients were classi®ed as hyperthyroid (39), subclinical hyperthyroid (44), euthyroid (46) and hypothyroid (38), based on the TSH and fT 4 (see Table 1 ). Compared with those who were euthyroid or hypothyroid, hyperthyroid patients were found to have signi®cantly low CK levels (P=0´0001), high ACE activity (P50´001) and elevated ALP levels (P50´001). The CK levels in subclinical hyperthyroid patients were not sig-ni®cantly different from those of hyperthyroid patients and were signi®cantly lower (P50´001) than those in the euthyroid and hypothyroid groups. ACE activity in subclinical hyperthyroid patients was comparable to that found in the euthyroid and hypothyroid patients. CK-MB and ALP, on the other hand, were less speci®c, with variable results overlapping between the different groups of patients.
DISCUSSION
In agreement with Docherty et al., 4 our study showed that hyperthyroidism is associated with signi®cantly low mean CK levels, high ACE activity and elevated ALP levels. CK remained signi®cantly low in subclinical hyperthyroid patients compared with the euthyroid and hypothyroid patients. In our previous study, this group of patients was also found to have elevated insulin-like growth factor binding protein-3 (IGFBP-3) levels. 5 Hence, apart from the suppressed TSH and elevated IGFBP-3, a low CK value is highly associated with subclinical thyrotoxicosis; moreover, the low CK value also indicates that low enzymatic activities in muscle tissues are still present in subclinical thyrotoxicosis, similar to that seen in the hyperthyroid state. As such, these patients should be closely monitored and perhaps continue to receive treatment.
On the other hand, while the high ACE activity and elevated ALP levels were observed only in the hyperthyroid patients, the considerable overlap in the CK-MB values between the subclinical hyperthyroid, euthyroid and hypothyroid groups suggests variability and non-speci®city of this enzyme.
In conclusion, our study shows that serum CK may be a good adjunct biochemical index of subclinical hyperthyroidism, and, with properly established reference ranges, its measurement may even be useful in assessing treatment for hyperthyroidism. 
All results are expressed as mean+standard error of the mean, unless otherwise stated. * Not signi®cantly different from the hyperthyroid group; ** not signi®cantly different from the euthyroid group; { P40´01 versus euthyroid or hypothyroid group; { P40´001 versus euthyroid or hypothyroid group. CI=con®dence interval; TSH=thyroidstimulating hormone; T 4 =thyroxine; T 3 =triiodothyronine; CK=creatine kinase; CK-MB=creatine kinase B subunit; ALP=alkaline phosphatase; ACE=angiotensin-converting enzyme.
